Table 2.
Clinical characteristics responders
| Demographic and clinical characteristics responders (n = 413) | ||
|---|---|---|
| Disease duration median years (IQR) | 10 (5 to 20) | |
| Age at diagnosis mean years (SD) | 50.3 (14.9) | |
| Arthritis medications number (%) | NSAIDs | 128 (31.0) |
| DMARDs | 339 (82.1) | |
| Glucocorticoids | 122 (29.5) | |
| Biologics | 74 (17.9) | |
| HAQ median score (IQR)b | 1.5 (0.75 to 2.0) | |
| FIS median score (IQR)a b | FISIF | 10 (6 to 14) |
| FISAP | 16 (7 to 23) | |
| Importance median score (IQR)a | 6 (3 to 8) | |
| Cope median score (IQR)a | 5 (3 to 7) | |
| Severity median score (IQR)a | 6 (3 to 8) | |
| Impact of foot problems on ability to work number (%) | Yes | 156 (37.8) |
| No | 98 (23.7) | |
| Not applicable | 159 (38.5) | |
| Time interval of last recalled foot examination number (%)b | 0–6 months | 89 (21.6) |
| > 6–12 months | 61 (14.8) | |
| > 12–18 months | 34 (8.3) | |
| > 18 months | 97 (23.5) | |
| Can’t remember | 31 (7.5) | |
| Never had feet examined | 100 (24.3) | |
a FIS IF Foot Impact Score foot impairment/ footwear restriction subscale, FIS AP FIS activity limitation/participation restriction subscale; Importance = importance of foot problems; Cope = ability to cope with foot problems; Severity = severity of foot problems
bHAQ admissible n = 404; FIS admissible n = 400; foot examination admissible n = 412; IQR = Interquartile range